Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Blue Ledge Capital is a venture capital firm founded to provide an alternative to traditional venture capital models. Established in New York, the firm operates without charging recurring management fees, instead focusing on a one-time syndication fee that typically ranges from 0-2%. This structure aligns the interests of the venture capital firm, investors, and portfolio companies through a standard 20% performance fee upon realization events. The firm emphasizes quality over quantity in its investments, allowing investors to design their own portfolios based on individual goals.
Blue Ledge Capital is supported by a group of institutional partners collectively referred to as '5 Roses,' which enhances its operational capabilities. The firm has a strong focus on innovative technologies and companies that have the potential to create significant impact across various sectors, including healthcare, biotech, food-agtech, and agtech. As of now, Blue Ledge Capital has invested in seven companies, showcasing its commitment to fostering growth in these critical areas.
Blue Ledge Capital invests in businesses committed to building the future, focusing on quality investments rather than mere asset accumulation. The firm targets innovative technologies across sectors such as healthcare, biotech, food-agtech, and agtech. Investments are made at the seed, Series A, and Series B stages, allowing for a diverse range of opportunities. Investors have the flexibility to choose their investment size on a case-by-case basis, which is a distinctive feature of Blue Ledge's approach.
The firm operates under a unique deal-by-deal syndication model, which allows for deal-by-deal approval and eliminates the pressure of management fees. This structure not only benefits the investors but also provides portfolio companies with the necessary support to achieve their growth objectives. Blue Ledge Capital is particularly interested in companies that demonstrate innovative technologies with the potential for significant impact, making it a compelling partner for startups in these sectors.
Blue Ledge Capital's portfolio includes seven notable companies, each contributing to innovative advancements in their respective fields:
This diverse portfolio reflects Blue Ledge Capital's commitment to investing in companies that are at the forefront of technological innovation and sustainability.
Andy Roche, CPA: Founder & CIO of Blue Ledge Capital, Andy Roche has a background in finance and investment management. He has led numerous successful investment rounds and is known for his expertise in structuring deals that align the interests of all parties involved. Roche's experience in the venture capital space has positioned him as a key player in fostering innovative startups.
To pitch Blue Ledge Capital, founders should submit their proposals through the firm's website at blueledgecap.com. It is advisable to include a comprehensive deck that outlines the business model, market opportunity, and technology details. The firm prefers warm introductions but will consider direct submissions. Response times may vary based on the volume of inquiries, so patience is recommended.
In November 2024, Blue Ledge Capital led a $16 million Series B round for Qnovia, a company focused on respiratory and smoking-cessation therapeutics. This investment highlights the firm's active role in supporting innovative healthtech solutions.
Blue Ledge Capital continues to promote its unique investment model, emphasizing quality over quantity in its investment strategy. The firm remains committed to aligning interests through its performance fee structure and flexible investment sizes.
What are Blue Ledge Capital's investment criteria?
Blue Ledge Capital focuses on early-stage and growth-stage companies in sectors such as healthcare, biotech, food-agtech, and agtech. The firm seeks innovative technologies that have the potential to create significant impact.
How can I pitch to Blue Ledge Capital?
Founders can pitch their ideas through the firm's website at blueledgecap.com. It is recommended to include a clear business model, market analysis, and details on the technology or product being developed.
What makes Blue Ledge Capital different from traditional VCs?
Blue Ledge Capital operates on a deal-by-deal syndication model, which allows investors to opt-in for each investment opportunity without the pressure of recurring management fees. This structure emphasizes quality investments over quantity.
What is the typical check size for investments?
Check sizes vary as investors can choose their allocations on a case-by-case basis. This flexibility allows for tailored investment strategies based on individual goals.
What is the firm's post-investment involvement like?
Blue Ledge Capital provides operational support and resources to its portfolio companies, leveraging its institutional backing to help them achieve their growth objectives.
What is the performance fee structure?
The firm charges a standard 20% performance fee upon realization events, aligning the interests of the firm, investors, and portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.